<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Physiotherapy, Balneology and Rehabilitation</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Physiotherapy, Balneology and Rehabilitation</journal-title><trans-title-group xml:lang="ru"><trans-title>Физиотерапия, бальнеология и реабилитация</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1681-3456</issn><issn publication-format="electronic">2413-2969</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">569340</article-id><article-id pub-id-type="doi">10.17816/569340</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original studies</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Evaluation of the results of complex medical rehabilitation of patients with polyposis rhinosinusitis in the long-term period</article-title><trans-title-group xml:lang="ru"><trans-title>Оценка результатов комплексной медицинской реабилитации пациентов с полипозным риносинуситом в отдалённом периоде</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6597-2167</contrib-id><contrib-id contrib-id-type="spin">4176-8850</contrib-id><name-alternatives><name xml:lang="en"><surname>Pelishenko</surname><given-names>Tatyana G.</given-names></name><name xml:lang="ru"><surname>Пелишенко</surname><given-names>Татьяна Георгиевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>канд. мед. наук</p></bio><email>doctor217@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5044-5265</contrib-id><contrib-id contrib-id-type="spin">1107-4372</contrib-id><name-alternatives><name xml:lang="en"><surname>Kruglova</surname><given-names>Larisa S.</given-names></name><name xml:lang="ru"><surname>Круглова</surname><given-names>Лариса Сергеевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><email>kruglovals@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1190-1440</contrib-id><contrib-id contrib-id-type="spin">2099-3854</contrib-id><name-alternatives><name xml:lang="en"><surname>Nagornev</surname><given-names>Sergey N.</given-names></name><name xml:lang="ru"><surname>Нагорнев</surname><given-names>Сергей Николаевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><email>drnag@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9707-3262</contrib-id><contrib-id contrib-id-type="spin">2491-7199</contrib-id><name-alternatives><name xml:lang="en"><surname>Boyarintsev</surname><given-names>Valery  V.</given-names></name><name xml:lang="ru"><surname>Бояринцев</surname><given-names>Валерий Владимирович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><email>wpx@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Clinical hospital 1 of the Department of Presidential Affairs of the Russian Federation</institution></aff><aff><institution xml:lang="ru">Клиническая больница № 1 Управления делами Президента Российской Федерации</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Central State Medical Academy of Department of Presidential Affairs</institution></aff><aff><institution xml:lang="ru">Центральная государственная медицинская академия Управления делами Президента Российской Федерации</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2023-12-07" publication-format="electronic"><day>07</day><month>12</month><year>2023</year></pub-date><volume>22</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>87</fpage><lpage>96</lpage><history><date date-type="received" iso-8601-date="2023-09-12"><day>12</day><month>09</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-09-13"><day>13</day><month>09</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Эко-Вектор</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder></permissions><self-uri xlink:href="https://rjpbr.com/1681-3456/article/view/569340">https://rjpbr.com/1681-3456/article/view/569340</self-uri><abstract xml:lang="en"><p><bold>BACKGROUND:</bold> Previous studies on the comparative evaluation of the effectiveness of the course application of therapeutic physical factors during the complex medical rehabilitation of patients with polypous rhinosinusitis showed a rather high efficiency of the additional use of complex physiotherapy (alternating magnetic field and low-intensity laser therapy) in enhancing the regression of the main clinical manifestations of polypous rhinosinusitis and improving the quality of life (QoL) of patients. Considering the chronic and often recurrent nature of polypous rhinosinusitis, along with the relief of the main clinical manifestations of the disease and improvement in the quality of life of patients after treatment, medical rehabilitation of patients should also cover the long-term period.</p> <p><bold>AIM: </bold>Evaluation of the results of complex medical rehabilitation of patients with polyposis rhinosinusitis in the long-term period (after 6, 12 and 18 months) and determination of the optimal time parameters for a repeated course of physiotherapy aimed at maintaining the achieved clinical effect and the level of quality of life of patients.</p> <p><bold>MATERIALS AND METHODS:</bold> The study was performed with the participation of 120 patients with moderate to severe polypous rhinosinusitis and uncontrolled course. All patients were divided into 4 groups by simple fixed randomization. The first group (control, 30 patients) received only basic therapy, including endonasal application of Nasonex 2 doses 2 times a day and daily twice daily lavage of the nasal mucosa. Patients of the second group (comparison group 1, 30 patients) were additionally injected subcutaneously with dupilumab at a dose of 300 μg once every two weeks. In the third group (comparison group 2, 30 patients), against the background of the administration of dupilumab, exposure to an alternating magnetic field was performed. using the apparatus MAGNIT Med TeCo. Patients of the fourth group (main group, 30 patients), in addition to the volume of treatment of patients of the third group, received low-intensity laser radiation of the red spectrum (633 nm) using the AZOR-2K-02 apparatus.</p> <p><bold>RESULTS:</bold> Positive dynamics in terms of assessed clinical indicators throughout the entire observation period was noted only in the comparison groups and the main group. The maximum severity of positive changes was determined in the main group after 6 and 12 months of rehabilitation, exceeding the achieved values in the group with dupilumab. The follow-up period made it possible to establish that 18 months after the start of rehabilitation, there were no significant differences between these groups. The dynamics of the parameters of the microcirculatory tissue system in the comparison groups and the main group in the long-term period indicated the formation of compensatory-adaptive processes aimed at eliminating congestion in the nasal mucosa and associated hypoxia, as well as the normalization of oxygen metabolism and trophism of tissues prone to chronic inflammation.</p> <p><bold>CONCLUSION:</bold> The results obtained convincingly prove the effectiveness of additional course use of an alternating magnetic field in combination with low-intensity laser therapy. The use of this technology, implemented against the background of ongoing biological therapy, shows its increased efficiency up to 12 months after the start of medical rehabilitation. It is advisable to conduct a second course of physiotherapy based on the complex use of an alternating magnetic field and low-intensity laser radiation 9–12 months after the start of medical rehabilitation.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование.</bold> Выполненные ранее исследования по сравнительной оценке эффективности курсового применения лечебных физических факторов в комплексной медицинской реабилитации больных полипозным риносинуситом показали достаточно высокую эффективность дополнительного применения физиотерапии (переменное магнитное поле + низкоинтенсивная лазеротерапия) в усилении регресса основных клинических проявлений заболевания и повышении качества жизни пациентов. Учитывая хронический и часто рецидивирующий характер полипозного риносинусита, медицинская реабилитация больных наряду с купированием основных клинических проявлений заболевания и улучшения качества жизни пациентов по окончании лечения должна охватывать и отдалённый период.</p> <p><bold>Цель исследования</bold><italic> </italic>― оценка результатов комплексной медицинской реабилитации больных полипозным риносинуситом в отдалённом периоде (через 6, 12 и 18 месяцев) и определение оптимальных временных параметров для повторного курса физиотерапии, направленного на сохранение достигнутого клинического эффекта и уровня качества жизни пациентов.</p> <p><bold>Материалы и методы.</bold> В исследование включены 120 пациентов с полипозным риносинуситом средней и тяжёлой степени и неконтролируемым течением. Методом простой фиксированной рандомизации все пациенты разделены на 4 группы: в группе 1 (контрольная, <italic>n</italic>=30) пациенты получали только базовую терапию (глюкокортикоид эндоназально и ежедневное двукратное промывание слизистой оболочки полости носа); в группе 2 (сравнения 1, <italic>n</italic>=30) дополнительно подкожно вводили дупилумаб; в группе 3 (сравнения 2, <italic>n</italic>=30) на фоне введения дупилумаба проводили воздействие переменным магнитным полем; в группе 4 (основная, <italic>n</italic>=30) дополнительно к объёму лечения пациентов группы 3 получали воздействие низкоинтенсивным лазерным излучением красного спектра (633 нм).</p> <p><bold>Результаты. </bold>Положительная динамика со стороны оцениваемых клинических показателей на протяжении всего периода наблюдения была отмечена только в группах сравнения и основной группе. Максимальная выраженность позитивных изменений определялась в основной группе через 6 и 12 месяцев реабилитации, превышая достигнутые значения в группе с дупилумабом. Последующий период наблюдения позволил установить, что через 18 месяцев от начала реабилитации достоверные различия между этими группами отсутствовали. Динамика параметров микроциркуляторно-тканевой системы в группах сравнения и основной группе в отдалённом периоде указывала на формирование компенсаторно-приспособительных процессов, направленных на устранение застойных явлений в слизистой оболочке полости носа и связанной с этим гипоксией, а также нормализацию кислородного обмена и трофики тканей, подверженных хроническому воспалению.</p> <p><bold>Заключение. </bold>Полученные результаты убедительно доказывают эффективность дополнительного курсового использования переменного магнитного поля в комплексе с низкоинтенсивной лазеротерапией. Является целесообразным проведение повторного курса физиотерапии на основе комплексного применения переменного магнитного поля и низкоинтенсивного лазерного излучения через 9–12 месяцев от начала медицинской реабилитации.</p></trans-abstract><kwd-group xml:lang="en"><kwd>dupilumab</kwd><kwd>medical rehabilitation</kwd><kwd>microcirculatory tissue system</kwd><kwd>low-intensity laser radiation</kwd><kwd>long-term results</kwd><kwd>alternating magnetic field</kwd><kwd>polypous rhinosinusitis</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>дупилумаб</kwd><kwd>медицинская реабилитация</kwd><kwd>микроциркуляторно-тканевая система</kwd><kwd>низкоинтенсивное лазерное излучение</kwd><kwd>отдалённые результаты</kwd><kwd>переменное магнитное поле</kwd><kwd>полипозный риносинусит</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Morse JC, Miller C, Senior B. Management of chronic rhinosinusitis with nasal polyposis in the era of biologics. J Asthma Allergy. 2021;14:873–882. doi: 10.2147/JAA.S258438</mixed-citation><mixed-citation xml:lang="ru">Morse J.C., Miller C., Senior B. Management of chronic rhinosinusitis with nasal polyposis in the era of biologics // J Asthma Allergy. 2021. Vol. 14. P. 873–882. doi: 10.2147/JAA.S258438</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Orlandi RR, Kingdom TT, Smith TL, et al. International consensus statement on allergy and rhinology: Rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021;11(3):213–739. doi: 10.1002/alr.22741</mixed-citation><mixed-citation xml:lang="ru">Orlandi R.R., Kingdom T.T., Smith T.L., et al. International consensus statement on allergy and rhinology: Rhinosinusitis 2021 // Int Forum Allergy Rhinol. 2021. Vol. 11, N 3. P. 213–739. doi: 10.1002/alr.22741</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Soler ZM, Sauer D, Mace J, et al. Impact of mucosal eosinophilia and nasal polyposis on quality-of-life outcomes after sinus surgery. Otolaryngol Head Neck Surg. 2010;142(1):64–71. doi: 10.1016/j.otohns.2009.10.005</mixed-citation><mixed-citation xml:lang="ru">Soler Z.M., Sauer D., Mace J., et al. Impact of mucosal eosinophilia and nasal polyposis on quality-of-life outcomes after sinus surgery // Otolaryngol Head Neck Surg. 2010. Vol. 142, N 1. P. 64–71. doi: 10.1016/j.otohns.2009.10.005</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Erskine SE, Hopkins C, Clark A, et al. Chronic rhinosinusitis and mood disturbance. Rhinology. 2017;55(2):113–119. doi: 10.4193/Rhin16.111</mixed-citation><mixed-citation xml:lang="ru">Erskine S.E., Hopkins C., Clark A., et al. Chronic rhinosinusitis and mood disturbance // Rhinology. 2017. Vol. 55, N 2. P. 113–119. doi: 10.4193/Rhin16.111</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Tomoum MO, Klattcromwell C, DelSignore A, et al. Depression and anxiety in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2015;5(8):674–681. doi: 10.1002/alr.21528</mixed-citation><mixed-citation xml:lang="ru">Tomoum M.O., Klattcromwell C., DelSignore A., et al. Depression and anxiety in chronic rhinosinusitis // Int Forum Allergy Rhinol. 2015. Vol. 5, N 8. P. 674–681. doi: 10.1002/alr.21528</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Turner JH, Chandra RK, Li P, et al. Identification of clinically relevant chronic rhinosinusitis endotypes using cluster analysis of mucus cytokines. J Allergy Clin Immunol. 2018;141(5):1895–1897.е7. doi: 10.1016/j.jaci.2018.02.002</mixed-citation><mixed-citation xml:lang="ru">Turner J.H., Chandra R.K., Li P., et al. Identification of clinically relevant chronic rhinosinusitis endotypes using cluster analysis of mucus cytokines // J Allergy Clin Immunol. 2018. Vol. 141, N 5. P. 1895–1897.е7. doi: 10.1016/j.jaci.2018.02.002</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Lee SE, Hopkins C, Mullol J, et al. Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies. Allergy. 2022;77(7):2211–2221. doi: 10.1111/all.15222</mixed-citation><mixed-citation xml:lang="ru">Lee S.E., Hopkins C., Mullol J., et al. Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies // Allergy. 2022. Vol. 77, N 7. P. 2211–2221. doi: 10.1111/all.15222</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Turner JH, Li P, Chandra RK. Mucus T helper 2 biomarkers predict chronic rhinosinusitis disease severity and prior surgical intervention. Int Forum Allergy Rhinol. 2018;8(10):1175–1183. doi: 10.1002/alr.22160</mixed-citation><mixed-citation xml:lang="ru">Turner J.H., Li P., Chandra R.K. Mucus T helper 2 biomarkers predict chronic rhinosinusitis disease severity and prior surgical intervention // Int Forum Allergy Rhinol. 2018. Vol. 8, N 10. P. 1175–1183. doi: 10.1002/alr.22160</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Abramovich SG, Larionova EM. Fundamentals of clinical physiotherapy in otorhinolaryngology. Irkutsk; 2011. 168 p. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Абрамович С.Г., Ларионова Е.М. Основы клинической физиотерапии в оториноларингологии. Иркутск, 2011. 168 с.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Buyavykh AG. Physical therapy in otorhinolaryngological practice. Practical guide. Moscow: Medical Information Agency; 2019. 368 p. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Буявых А.Г. Физическая терапия в оториноларингологической практике. Практическое руководство. Москва: МИА, 2019. 368 с.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Moskvin SV, Khadartsev AA. Methods of effective laser therapy in the treatment of patients with bronchial asthma (literature review). Bulletin of New Medical Technologies. Electronic edition. 2019;(5):117–148. (In Russ). doi: 10.24411/2075-4094-2019-16522</mixed-citation><mixed-citation xml:lang="ru">Москвин С.В., Хадарцев А.А. Методы эффективной лазерной терапии при лечении больных бронхиальной астмой (обзор литературы) // Вестник новых медицинских технологий. Электронное издание. 2019. № 5. С. 117–148. doi: 10.24411/2075-4094-2019-16522</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Moskvin SV. Fundamentals of laser therapy. Series "Effective laser therapy". Vol. 1. Moscow-Tver: Triada; 2016. 896 p. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Москвин С.В. Основы лазерной терапии. Серия «Эффективная лазерная терапия». Т. 1. Москва-Тверь: Триада, 2016. 896 с.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Ivanov DV, Tokareva SV. Selected issues of magnetotherapy (a brief review of the literature). Bulletin of New Medical Technologies. Electronic edition. 2021;15(4):94–102. (In Russ). doi: 10.24412/2075-4094-2021-4-3-4</mixed-citation><mixed-citation xml:lang="ru">Иванов Д.В., Токарева С.В. Избранные вопросы магнитотерапии (краткий обзор литературы) // Вестник новых медицинских технологий. Электронное издание. 2021. Т. 15, № 4. С. 94–102. doi: 10.24412/2075-4094-2021-4-3-4</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(Suppl. 29):1–464. doi: 10.4193/Rhin20.600</mixed-citation><mixed-citation xml:lang="ru">Fokkens W.J., Lund V.J., Hopkins C., et al. European position paper on rhinosinusitis and nasal polyps 2020 // Rhinology. 2020. Vol. 58, Suppl. 29. P. 1–464. doi: 10.4193/Rhin20.600</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Bachert C, Han JK, Wagenmann M, et al. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management. J Allergy Clin Immunol. 2021;147(1):29–36. doi: 10.1016/j.jaci.2020.11.013</mixed-citation><mixed-citation xml:lang="ru">Bachert C., Han J.K., Wagenmann M., et al. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management // J Allergy Clin Immunol. 2021. Vol. 147, N 1. P. 29–36. doi: 10.1016/j.jaci.2020.11.013</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Gorbunov SA, Rusetsky YuYu, Kudryashov SE, et al. Review of international questionnaires and questionnaires for assessing the quality of life in acute and chronic rhinosinusitis. Russian Rhinology. 2021;29(2):97–106. (In Russ). doi: 10.17116/rosrino20212902197</mixed-citation><mixed-citation xml:lang="ru">Горбунов С.А., Русецкий Ю.Ю., Кудряшов С.Е., и др. Обзор международных опросников и анкет оценки качества жизни при остром и хроническом риносинусите // Российская ринология. 2021. Т. 29, № 2. С. 97–106. doi: 10.17116/rosrino20212902197</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Braid J, Islam L, Gugiu C, et al. Meaningful changes for efficacy outcomes in patients with chronic rhinosinusitis with nasal polyps. World Allergy Organ J. 2023;16(5):100776. doi: 10.1016/j.waojou.2023.100776</mixed-citation><mixed-citation xml:lang="ru">Braid J., Islam L., Gugiu C., et al. Meaningful changes for efficacy outcomes in patients with chronic rhinosinusitis with nasal polyps // World Allergy Organ J. 2023. Vol. 16, N 5. Р. 100776. doi: 10.1016/j.waojou.2023.100776</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: Developing guidance for clinical trials. J Allergy Clin Immunol. 2006;118(5 Suppl):S17–61. doi: 10.1016/j.jaci.2006.09.005</mixed-citation><mixed-citation xml:lang="ru">Meltzer E.O., Hamilos D.L., Hadley J.A., et al. Rhinosinusitis: Developing guidance for clinical trials // J Allergy Clin Immunol. 2006. Vol. 118, N 5, Suppl. P. S17–61. doi: 10.1016/j.jaci.2006.09.005</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Beresten NF, Sandrikov VA, Fedorova SI, eds. Functional diagnostics. National leadership. Moscow: GEOTAR-Media; 2022. 784 р. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Берестень Н.Ф., Сандриков В.А., Федорова С.И., ред. Функциональная диагностика. Национальное руководство. Москва: ГЭОТАР-Медиа, 2022. 784 с.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Ponomarenko GN. Topical issues of physiotherapy. Selected lectures. Saint Petersburg: Military Medical Academy; 2010. Р. 112–135. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Пономаренко Г.Н. Актуальные вопросы физиотерапии. Избранные лекции. Санкт-Петербург: ВМА, 2010. С. 112–135.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Benkov AA, Nagornev SN, Frolkov VK, et al. Evaluation of nonspecific mechanisms of effectiveness of course combined use of low-frequency electrostatic field and transcranial magnetotherapy in patients with metabolic syndrome. Kurortnaya meditsina. 2022;(2):12–23. (In Russ). doi: 10.51871/2304-0343_2022_2_12</mixed-citation><mixed-citation xml:lang="ru">Беньков А.А., Нагорнев С.Н., Фролков В.К., и др. Оценка неспецифических механизмов эффективности курсового сочетанного применения низкочастотного электростатического поля и транскраниальной магнитотерапии у пациентов с метаболическим синдромом // Курортная медицина. 2022. № 2. С. 12–23. doi: 10.51871/2304-0343_2022_2_12</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">Rubinsky AV, Linkova NS, Chalisova NI, et al. Epigenetic regulation of adaptogenesis in pathology and aging. Uspekhi gerontologii. 2021;34(1):10–17. (In Russ). doi: 10.34922/AE.2021.34.1.001</mixed-citation><mixed-citation xml:lang="ru">Рубинский А.В., Линькова Н.С., Чалисова Н.И., и др. Эпигенетическая регуляция адаптогенеза при патологии и старении // Успехи геронтологии. 2021. Т. 34, № 1. С. 10–17. doi: 10.34922/AE.2021.34.1.001</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">McGee SL, Hargreaves M. Epigenetics and exercise. Trends Endocrinol Metab. 2019;30(9):636–645. doi: 10.1016/j.tem.2019.06.002</mixed-citation><mixed-citation xml:lang="ru">McGee S.L., Hargreaves M. Epigenetics and exercise // Trends Endocrinol Metab. 2019. Vol. 30, N 9. P. 636–645. doi: 10.1016/j.tem.2019.06.002</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">Fenixova LV, Gurina OYu. Ultrastructural changes in microhemodynamics in conditions of chronic inflammation of the mucous membrane of the paranasal sinuses. Detskaya bol'nitsa. 2013;(3):40–42. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Фениксова Л.В., Гурина О.Ю. Ультраструктурные изменения микрогемодинамики в условиях хронического воспаления слизистой оболочки околоносовых пазух // Детская больница. 2013. № 3. С. 40–42.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">Fokkens W, van Der Lans R, Reitsma S. Dupilumab for the treatment of chronic rhinosinusitis with nasal polyposis. Expert Opin Biol Ther. 2021;21(5):575–585. doi: 10.1080/14712598.2021.1901881</mixed-citation><mixed-citation xml:lang="ru">Fokkens W., van Der Lans R., Reitsma S. Dupilumab for the treatment of chronic rhinosinusitis with nasal polyposis // Expert Opin Biol Ther. 2021. Vol. 21, N 5. P. 575–585. doi: 10.1080/14712598.2021.1901881</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">Fujieda S, Matsune S, Takeno S, et al. Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS-52 is unaffected by eosinophilic status. Allergy. 2022;77(1):186–196. doi: 10.1111/all.14906</mixed-citation><mixed-citation xml:lang="ru">Fujieda S., Matsune S., Takeno S., et al. Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS-52 is unaffected by eosinophilic status // Allergy. 2022. Vol. 77, N 1. P. 186–196. doi: 10.1111/all.14906</mixed-citation></citation-alternatives></ref></ref-list></back></article>
